Brief: Inozyme Pharma Appoints Kurt Gunter As Chief Medical Officer
June 7 (Reuters) - Inozyme Pharma Inc INZY.O :
* INOZYME PHARMA APPOINTS KURT GUNTER, M.D., AS CHIEF
MEDICAL
OFFICER
* INOZYME PHARMA APPOINTS KURT GUNTER, M.D., AS CHIEF
MEDICAL
OFFICER
Source text for Eikon: ID:nGNXb4YFsz
Further company coverage: INZY.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Inozyme Pharma
See all newsBrief: Inozyme Pharma postpones 2025 annual meeting of stockholders
U.S. RESEARCH ROUNDUP-Advansix, Cognizant, Inozyme Pharma
U.S. STOCKS ON THE MOVE-Netflix, Acadia Pharma, CoreWeave
U.S. STOCKS ON THE MOVE-Inozyme Pharma, Emerson Electric, Stanley Black & Decker
Inozyme Pharma rises over 175% on $270 million buyout deal with BioMarin